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Aim: Due to widespread availability of archived neonatal screening samples, some 
investigators propose genome-wide association study designs that utilize de-identified 
DNA samples. The objective of this study was to determine parental perceptions of 
potential risks and benefits associated with future genetic biorepository studies that 
would utilize de-identified, archived DNA samples from NICU subjects of varying 
ethnicity and gestational ages. 
Methods: A 12 question, IRB approved survey was distributed to the parents of graduate 
NICU patients. Of 283 surveys distributed, 109 surveys were completed; 107 after direct 
personal encounter and 2 via mail. After eliciting informed consent, direct personal 
contact occurred during a scheduled NICU follow up visit. 
Results: 95% of directly contacted parents completed the survey, whereas only 1% of 
surveys distributed via mail were completed (p<0.001). Of the completed surveys, 89% 
of the parents were comfortable with the use of their child’s previously drawn, discarded 
samples for future genetic research. 83% reported that they would likely consent to their 
child’s participation in a future genetic biorepository. Conversely, the point estimate of 
22% of parents (95% confidence interval 14.7-31.0) would either decline to archive 
samples or participate in a future genetic biorepository study. Among the 83% of parents 
likely to consent, the following reasons were listed: perceived potential benefit to their 
own child (19.5%), to other children (37%), or to science (38%). Among the 17% of 
parents unlikely to participate, the following reasons were listed: perceived potential 
harm to their child (26%), potential discrimination (15%), potential privacy issues (15%) 
and fear of potential new information or outcomes (10%). Fischer exact test did not 
reveal any statistically significant differences between parental responses stratified by 
self-identified ethnicity or gestational age at birth.  
Conclusion: Although most NICU parents will consent to a NICU genetic biorepository 
study, significant minorities perceive significant risks and would decline storage of their 
child’s de-identified DNA for future genetic research. The fraction of parents who 
decline is comparable across a range of self-identified ethnicity and gestational ages. In 
order to protect all potential research subjects, prospective informed consent is a 
requirement for ethical study design.  
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Bioavailability of vitamin D in obesity: an overview 
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Background: Obesity has been linked to many conditions including inflammation, 
fatigue, muscle and bone aches, pressure sores, and high blood pressure. Vitamin D, a 
steroid hormone, and leptin, a peptide hormone, are two essential factors that help target 
obesity in the general population. Although the association between vitamin D and 
obesity has been made clear through calcium regulation, the link between vitamin D and 
leptin still seems to be unclear. 
Objective: To assess the link between low levels of vitamin D, leptin and obesity. 
Results: Vitamin D has recently been linked to obesity through an inverse relationship. 
The content of the vitamin D3 precursor 7-dehydrocholesterol in the skin of obese and 
non-obese subjects has not been reported to differ significantly. There appears to be a 
spike in leptin levels with decreased vitamin D levels in obesity. 
Conclusion: Different aspects associated with vitamin D deficiency in obese individuals 
have been explored. Vitamin D insufficiency is associated with obesity due to the 
decreased bioavailability of vitamin D3, instead it is deposited in adipose tissue. In vitro 
studies indicate that obesity does not affect the cutaneous production of vitamin D. 
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